![Kevin G. Peters](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kevin G. Peters
Directeur Technique/Scientifique/R&D chez
Aerpio Therapeutics LLC
Profil
Kevin G.
Peters is currently the Chief Scientific Officer at Aerpio Therapeutics, Inc. He previously worked as the Group Medical Director at Bristol Myers Squibb Co., Head-Therapeutic Angiogenesis Research at Procter & Gamble Pharmaceuticals, Inc., Associate Professor-Medicine & Pharmacology at Duke University Medical Center, and CSO, Vice President-Research & Development at Akebia Therapeutics, Inc. He was also the Chief Scientific & Medical Officer at Aerpio Pharmaceuticals, Inc. from 2019 to 2021.
Peters received his undergraduate degree from Augustana University and his doctorate from the University of Iowa.
Postes actifs de Kevin G. Peters
| Sociétés | Poste | Début |
|---|---|---|
Aerpio Therapeutics LLC
 Aerpio Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Kevin G. Peters
| Sociétés | Poste | Fin |
|---|---|---|
| AERPIO PHARMACEUTICALS | Directeur Technique/Scientifique/R&D | 31/03/2021 |
Duke University Medical Center
 Duke University Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| BRISTOL-MYERS SQUIBB COMPANY | Directeur Technique/Scientifique/R&D | - |
Procter & Gamble Pharmaceuticals, Inc.
 Procter & Gamble Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Directeur Technique/Scientifique/R&D | - |
| AKEBIA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Kevin G. Peters
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
18
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Aerpio Therapeutics LLC
Aerpio Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases | Health Technology |
Procter & Gamble Pharmaceuticals, Inc.
Procter & Gamble Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
Augustana University
 Augustana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Iowa
 University of Iowa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duke University Medical Center
Duke University Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akebia Therapeutics, Inc.
 Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases | Health Technology |
Aerpio Pharmaceuticals, Inc.
 Aerpio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
